Eisai Ltd ADR (OP: ESALY )Price and VolumeDetailed Quote
Top NewsMore News
Lecanemab Receives Priority Review Status in Japan
January 29, 2023
PerformanceMore NewsRead More
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
Top Picks For 2023: Catalyst Pharmaceuticals
January 02, 2023
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
December 22, 2022
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
December 18, 2022
Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock
December 18, 2022
Why 2023 Could Be a Big Year for Biogen
December 07, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|